Medigene Ag Stock Net Income
| MDGEFDelisted Stock | USD 2.59 0.00 0.00% |
Medigene AG fundamentals help investors to digest information that contributes to Medigene's financial success or failures. It also enables traders to predict the movement of Medigene Pink Sheet. The fundamental analysis module provides a way to measure Medigene's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medigene pink sheet.
Medigene |
Medigene AG Company Net Income Analysis
Medigene's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Medigene Net Income | (9.98 M) |
Most of Medigene's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medigene AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Medigene AG reported net income of (9.98 Million). This is 102.93% lower than that of the Healthcare sector and 114.25% lower than that of the Biotechnology industry. The net income for all United States stocks is 101.75% higher than that of the company.
Medigene Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medigene's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Medigene could also be used in its relative valuation, which is a method of valuing Medigene by comparing valuation metrics of similar companies.Medigene is currently under evaluation in net income category among its peers.
Medigene Fundamentals
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0887 | |||
| Profit Margin | 0.31 % | |||
| Operating Margin | 0.32 % | |||
| Current Valuation | 30.5 M | |||
| Shares Outstanding | 24.56 M | |||
| Shares Owned By Insiders | 6.66 % | |||
| Shares Owned By Institutions | 4.62 % | |||
| Price To Earning | 5.26 X | |||
| Price To Book | 0.92 X | |||
| Price To Sales | 1.86 X | |||
| Revenue | 10.46 M | |||
| Gross Profit | 9.1 M | |||
| EBITDA | (6.49 M) | |||
| Net Income | (9.98 M) | |||
| Cash And Equivalents | 39.38 M | |||
| Cash Per Share | 1.60 X | |||
| Total Debt | 3.73 M | |||
| Debt To Equity | 0.06 % | |||
| Current Ratio | 6.04 X | |||
| Book Value Per Share | 2.41 X | |||
| Cash Flow From Operations | (10.75 M) | |||
| Earnings Per Share | 0.42 X | |||
| Price To Earnings To Growth | (0.36) X | |||
| Target Price | 18.82 | |||
| Number Of Employees | 61 | |||
| Beta | 0.88 | |||
| Market Capitalization | 56.49 M | |||
| Total Asset | 59.47 M | |||
| Z Score | 9.0 | |||
| Net Asset | 59.47 M |
About Medigene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medigene AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medigene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medigene AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Medigene Pink Sheet
If you are still planning to invest in Medigene AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigene's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |